A5107173631- Management of metastatic bone disease
- Cancer Diagnosis and Treatment
- Bone health and treatments
- Cancer survivorship and care
- Gastric Cancer Management and Outcomes
- Brain Metastases and Treatment
- Colorectal and Anal Carcinomas
- Medical Imaging and Pathology Studies
- Colorectal Cancer Surgical Treatments
- Advanced Radiotherapy Techniques
- Bone and Joint Diseases
- Palliative Care and End-of-Life Issues
- Colorectal Cancer Treatments and Studies
- Helicobacter pylori-related gastroenterology studies
- Nonmelanoma Skin Cancer Studies
- Spine and Intervertebral Disc Pathology
- Colorectal Cancer Screening and Detection
- Genetic factors in colorectal cancer
- Anesthesia and Pain Management
- Hematological disorders and diagnostics
- Lung Cancer Research Studies
- Medical Imaging Techniques and Applications
- Nausea and vomiting management
- Cancer-related Molecular Pathways
- Meningioma and schwannoma management
Bank of Cyprus Oncology Center
2014-2025
Health Sciences Centre
2024
Sunnybrook Health Science Centre
2024
Leiden University
2024
Creative Research Enterprises (United States)
2018
Nicosia General Hospital
2018
Cyprus Research and Innovation Center (Cyprus)
2018
University of Patras
2006-2009
National Public Health Laboratory
2009
The number of cancer survivors is growing steadily and increasingly, clinical trials are being designed to include long-term follow-up assess not only survival, but also late effects health-related quality life (HRQOL). Therefore it essential develop patient-reported outcome measures (PROMs) that capture the full range issues relevant disease-free survivors. objectives this project are: 1) a European Organisation for Research Treatment Cancer (EORTC) questionnaire captures physical, mental...
Abstract BACKGROUND: The objective of this international field study was to test the reliability, validity, and responsiveness European Organization for Research Treatment Cancer (EORTC) QLQ‐BM22 module assess health‐related quality life (HRQOL) in patients with bone metastases. METHODS: Patients undergoing a variety metastases‐specific treatments were accrued. administered QLQ‐C30 at baseline 1 follow‐up time point internationally. A debriefing questionnaire determine patient acceptability...
Pain from spinal metastases can result in significant impact to patients' quality of life. Conventional external beam radiation therapy (cEBRT) has long been shown be effective the pain control patients with metastases. With advancement therapy, stereotactic body (SBRT) increasingly adopted for treatment Multiple randomised controlled trials (RCT) have performed evaluate whether SBRT provides better relief compared cEBRT. Previous meta-analyses showed that significantly complete response at...
Since scarce data exist on the pathogenesis of nasopharyngeal carcinoma in Caucasian patients, we attempted to elucidate responsible molecular pathways this patient population.Formalin-fixed paraffin-embedded tumor tissue samples from 107 diagnosed with locally-advanced and treated chemotherapy or chemo-radiotherapy, were analyzed by immunohistochemistry for expression following proteins: E-cadherin, P-cadherin, Fascin-1, Cyclin D1, COX-2, EGFR, VEGF-A, VEGF-C, VEGFR-2, VEGFR-3, ERCC1, p53,...
Objective: Health related quality of life (HRQOL) is a multidimensional concept that especially important for cancer patients with bone metastases, as maintaining and improving HRQOL often the main focus treatment. This study aims to determine factors may influence HRQOL, which in turn treatment care patients. Methods: Patients (n=396) completed European Organisation Research Treatment Cancer (EORTC) Quality Life Questionnaire (QLQ) Bone Metastases module (BM22) at baseline. The EORTC...
The European Organization of Research and Treatment Cancer (EORTC) Quality Life Questionnaire - Core 15 Palliative (EORTC QLQ-C15-PAL) was developed to assess quality life (QOL) for the palliative cancer population decrease patient burden. purpose this study compare predictive factors well-being in QLQ-C15-PAL extracted from EORTC 30 (QLQ-C30) with QLQ-C30 itself.Patients advanced referred treatment bone metastases completed QLQ-C30. Fifteen items were Univariate multivariate analyses used...